Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a multi-centre, double-blind, randomized phase III trial comparing metformin to placebo in patients with advanced prostate cancer starting (or have recently started) androgen deprivation therapy (ADT).
Epistemonikos ID: fea93b5e41d731d350437cdf4761a9726b776cd5
First added on: May 20, 2024